Expert Analysis

Unpacking Trump Admin Plans For Value-Based Care

Recent developments from the Center for Medicare and Medicaid Innovation suggest the Trump administration intends ... (more story)

What To Expect For Stem Cell Regulation Under Trump Admin

The new administration's push for deregulation, plus the post-Chevron legal landscape, and momentum from key polit... (more story)

How Importers Can Minimize FCA Risks Of Tariff Mitigation

False Claims Act risks are inherent in many tariff mitigation strategies, making it important for importers to imp... (more story)

Deals & Corporate Governance More

Taxation With Representation: Norton Rose, Latham, Ashurst

In this week's Taxation With Representation, Dollar Tree sells its Family Dollar business to private equity firms, eye care company Alcon buys medical technology company Lensar and Ithaca Energy PLC buys the U... (more story)

Sotomayor Urges Caution On Nondelegation Doctrine Revamp

U.S. Supreme Court Justice Sonia Sotomayor cautioned her colleagues during oral arguments Wednesday against using a challenge to the Federal Communications Commission's administration of a broadband subsidy pr... (more story)

7 Firms Compete To Lead Novo Nordisk Securities Suit

Levi & Korsinsky LLP, Pomerantz LLP and the Rosen Law Firm PA are among seven law firms vying to lead proposed class claims accusing Novo Nordisk A/S of misleading investors about a clinical trial for an obesity drug.

Ex-CEO Says McGuireWoods Can't Rehash Immunity Appeal

McGuireWoods LLP and one of its former partners are rehashing immunity defenses in a last-ditch effort to dodge a long-running defamation case, the former CEO of a managed care organization told the North Caro... (more story)

Healthcare Deals This Week: Merck, J&J And Startups Galore

It's been a busy week for healthcare. Several Big Pharma players inked licensing deals in areas like cardiology and cancer and others said they would up their U.S. manufacturing investments, continuing a growi... (more story)

Pension Seeks To Opt Class Out Of Cutera Ch. 11 Releases

A pension fund heading up a class action against skin care technology group Cutera has urged a Texas bankruptcy court to find the shareholder has authority to opt all class members out of the company's Chapter 11 plan.

Digital Health & Technology More

Meet The Attys Helping 23AndMe Through Ch. 11

DNA testing company 23andMe Holding Co. enlisted a group of attorneys from Carmody MacDonald PC and Paul Weiss Rifkind Wharton & Garrison LLP to help it address $214 million in debt as it tries to sell its bus... (more story)

23andMe Says Ch. 11 Privacy Ombudsman Not Required

DNA testing company 23andMe Inc.'s customer data will be protected in Chapter 11, its attorneys told a Missouri bankruptcy judge Wednesday as it argued that the appointment of a consumer privacy ombudsman is not required.

Catching Up With New Bankruptcy Case Action

23andMe Holding Co. entered Chapter 11 to sell its business and address $214 million in debt; Danimer Scientific Inc., which makes plastics alternatives, entered Chapter 11 to wind down while it tends to its r... (more story)

Period App Users Get $3.5M In Privacy Deal With Analytics Co.

A defunct mobile analytics company caught up in a proposed class action alleging a menstruation tracking app impermissibly shared health information with Google and others has agreed to a $3.5 million settleme... (more story)

Children's Hospital Axes Suit Over Meta Info Sharing, For Now

A Minnesota federal judge tossed a proposed class action alleging a children's hospital used ad tracking software on its website that disclosed minor patients' sensitive information with Meta Platforms Inc., G... (more story)

Seattle Biotech Duped Investors On Drug Progress, Suit Says

Seattle's Sana Biotechnology Inc. is the target of a proposed class action filed on Monday by a shareholder who alleges the company misled investors about its ability to develop genetic therapy treatments for ... (more story)

Policy & Compliance More

Colo. Beats Amgen's Drug Price Cap Challenge, For Now

A Colorado federal judge Friday threw out Amgen's challenge to the Centennial State's drug price cap system, finding that Amgen is not subject to "direct regulation" under the law it's challenging and therefor... (more story)

Janssen Owes Additional $1.5B In HIV Prescription Trial

A New Jersey federal judge on Friday added nearly $1.3 billion in penalties and $240 million in damages to a whistleblower False Claims Act verdict against Janssen over the off-label marketing of two HIV medic... (more story)

Plan Administrator Wins Electric Co.'s Union Healthcare Fight

An electric company can't use the Employee Retirement Income Security Act to claw back contributions to a union healthcare plan that weren't put toward benefits, a New York federal judge said Friday, tossing t... (more story)

PE Firm Hits Back Against Medical Device Coating Challenge

Private equity firm GTCR BC Holdings LLC told a Federal Trade Commission in-house judge Friday the commission has a warped view of the medical device coatings market, as the firm fights a bid to block its $627... (more story)

Ex-Chicago Firefighter's Vaccine Bias Suit Fails, For Now

The city of Chicago dodged a former firefighter's lawsuit claiming he was fired for not complying with the city's COVID-19 vaccination policy after being given a religious exemption, with an Illinois federal j... (more story)

Feds Settle NC Insurer's Medicare Reimbursement Suit

The U.S. Department of Health and Human Services has settled a North Carolina state-created insurance association's suit arguing it did not need to pay back the federal Medicare program for claims that should ... (more story)